329 related articles for article (PubMed ID: 33135196)
21. Sialadenoma papilliferum-like intraductal papillary tumour: an emerging entity with intercalated duct differentiation showing MAPK pathway activation in both ductal and myoepithelial cells.
Oh KY; Kim JH; Hong SD; Yoon HJ
Pathology; 2024 Feb; 56(1):52-58. PubMed ID: 37973455
[TBL] [Abstract][Full Text] [Related]
22. A rare case of high-grade intraductal carcinoma of the upper lip: immunohistochemical and genetic analyses.
Kusafuka K; Ito I; Hirata K; Miyamoto K; Shimizu T; Satomi H; Inagaki H; Suzuki M
Med Mol Morphol; 2021 Sep; 54(3):281-288. PubMed ID: 34009452
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Molecular Profiling of Oncocytic Salivary Gland Malignancies.
Zaccarini DJ; Sivapiragasam A; Sokol E; Huang RSP; Pavlick DC; Janovitz T; Nasr MR; Ross JS
Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):609-613. PubMed ID: 35876752
[TBL] [Abstract][Full Text] [Related]
24. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
Skálová A; Baněčková M; Laco J; Di Palma S; Agaimy A; Ptáková N; Costes-Martineau V; Petersson BF; van den Hout MFCM; de Rezende G; Klubíčková N; Koblížek M; Koshyk O; Vaneček T; Leivo I
Am J Surg Pathol; 2022 Feb; 46(2):268-280. PubMed ID: 34510113
[TBL] [Abstract][Full Text] [Related]
25. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm.
Nakaguro M; Urano M; Ogawa I; Hirai H; Yamamoto Y; Yamaguchi H; Tanigawa M; Matsubayashi J; Hirano H; Shibahara J; Tada Y; Tsuzuki T; Okada Y; Sato Y; Ikeda K; Sukeda A; Honda Y; Mikami Y; Nagao T
Histopathology; 2020 Feb; 76(3):411-422. PubMed ID: 31505033
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis.
Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF
Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022
[No Abstract] [Full Text] [Related]
27. Low-grade intraductal carcinoma of salivary gland: report of 3 cases with marked apocrine differentiation.
Weinreb I; Tabanda-Lichauco R; Van der Kwast T; Perez-Ordoñez B
Am J Surg Pathol; 2006 Aug; 30(8):1014-21. PubMed ID: 16861974
[TBL] [Abstract][Full Text] [Related]
28. Sclerosing Polycystic "Adenosis" of Salivary Glands: A Neoplasm Characterized by PI3K Pathway Alterations More Correctly Named Sclerosing Polycystic Adenoma.
Bishop JA; Gagan J; Baumhoer D; McLean-Holden AL; Oliai BR; Couce M; Thompson LDR
Head Neck Pathol; 2020 Sep; 14(3):630-636. PubMed ID: 31605313
[TBL] [Abstract][Full Text] [Related]
29. Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions.
Skálová A; Agaimy A; Stanowska O; Baneckova M; Ptáková N; Ardighieri L; Nicolai P; Lombardi D; Durzynska M; Corcione L; Laco J; Koshyk O; Žalud R; Michal M; Vanecek T; Leivo I
Am J Surg Pathol; 2020 Dec; 44(12):1612-1622. PubMed ID: 33002921
[TBL] [Abstract][Full Text] [Related]
30. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
Su YJ; Lee YH; Jin YT; Hsieh MS
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
[TBL] [Abstract][Full Text] [Related]
31. Oncocytic and apocrine epithelial myoepithelial carcinoma: novel variants of a challenging tumor.
Seethala RR
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S77-84. PubMed ID: 23821213
[TBL] [Abstract][Full Text] [Related]
32. Intraductal Carcinoma of Salivary Gland Originating from an Intraparotid Lymph Node: A Case Report.
Lin SC; Ko RT; Kang BH; Wang JS
Malays J Pathol; 2019 Aug; 41(2):207-211. PubMed ID: 31427558
[TBL] [Abstract][Full Text] [Related]
33. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
[TBL] [Abstract][Full Text] [Related]
34. What is hiding behind S100 protein and SOX10 positive oncocytomas? Oncocytic pleomorphic adenoma and myoepithelioma with novel gene fusions in a subset of cases.
Baněčková M; Uro-Coste E; Ptáková N; Šteiner P; Stanowska O; Benincasa G; Colella G; Vondrák J; Michal M; Leivo I; Skálová A
Hum Pathol; 2020 Sep; 103():52-62. PubMed ID: 32673681
[TBL] [Abstract][Full Text] [Related]
35. Assessment of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in benign and malignant salivary gland neoplasms.
Bodnar M; Burduk P; Antosik P; Jarmuz-Szymczak M; Wierzbicka M; Marszalek A
J Oral Pathol Med; 2017 May; 46(5):340-345. PubMed ID: 27682157
[TBL] [Abstract][Full Text] [Related]
36. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
Taverna C; Baněčková M; Lorenzon M; Palomba A; Franchi A; Skalova A; Agaimy A
Histopathology; 2021 Sep; 79(3):315-324. PubMed ID: 32931030
[TBL] [Abstract][Full Text] [Related]
37. Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion.
Bishop JA; Weinreb I; Swanson D; Westra WH; Qureshi HS; Sciubba J; MacMillan C; Rooper LM; Dickson BC
Am J Surg Pathol; 2019 Aug; 43(8):1023-1032. PubMed ID: 31094920
[TBL] [Abstract][Full Text] [Related]
38. Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study.
Jalaly JB; Sanati S; Chernock RD; Dibe DG; El-Mofty SK
Head Neck Pathol; 2018 Dec; 12(4):488-492. PubMed ID: 29302899
[TBL] [Abstract][Full Text] [Related]
39. Oncocytoid Salivary Tumors: Differential Diagnosis and Utility of Newly Described Immunohistochemistry.
Katabi N
Head Neck Pathol; 2024 Mar; 18(1):20. PubMed ID: 38502259
[TBL] [Abstract][Full Text] [Related]
40. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
